# Reviewer ECp3 — Score: 3 (Weak Accept)
**Confidence: 3 (Moderate)**

## Strengths
- Targets pain-point of clinical trial eligibility criteria
- Defines a novel medical question with curated benchmark dataset
- Demonstrates significant real-world impact

## Weaknesses
- **W1: No training/finetuning explored.** For real-world use, finetuning SOTA models could maximize performance.
- **W2: No ablation studies** for alternative framework designs.
- **W3: Data leakage concern.** Current LLMs may have been pretrained on data overlapping with the benchmark, leading to unfair evaluation.

## Suggestion
Splitting dataset and doing some finetuning would strengthen the work's impact.
